Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,024.34 +5.95 (+0.12%) Dow
37,973.24 +69.95 (+0.18%) Nasdaq
15,656.76 +51.28 (+0.33%) Bitcoin USD
58,360.09 +1,187.80 (+2.08%) CMC Crypto 200
1,261.63 -9.12 (-0.72%)
ABT May 2024 125.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:39PM EDT. Market open.
| Previous close | 18.40 |
| Open | 18.63 |
| Bid | 18.75 |
| Ask | 20.25 |
| Strike | 125.00 |
| Expiry date | 2024-05-17 |
| Day's range | 18.00 - 18.64 |
| Contract range | N/A |
| Volume | |
| Open interest | 77 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.